(PDF) Comparative Pharmacokinetics and Pharmacodynamics of

Comparative Pharmacokinetics and Pharmacodynamics of the New Propofol Prodrug GPI 15715 and Propofol Emulsion: Retraction

Anesthesiology - United States

doi 10.1097/aln.0b013e3181d64749

Full Text

Abstract

Available in full text

Categories

Date

April 1, 2010

Authors

Unknown

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Origins of Yersinia Pestis Sensitivity to the Arylomycin Antibiotics and the Inhibition of Type I Signal Peptidase

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Inhibition of the Sole Type I Signal Peptidase of Mycobacterium Tuberculosis Is Bactericidal Under Replicating and Nonreplicating Conditions

Journal of Bacteriology

Molecular Biology

English

Optimization of a Lactam Scaffold for Antibacterial Activity via the Inhibition of Bacterial Type I Signal Peptidase

English

Targeting Type III Secretion in Yersinia Pestis

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Structure and Regulation of the Yersinia Pestis yscBCDEF Operon.

Journal of Bacteriology

Molecular Biology

English

Staphylococcus Aureus Type I Signal Peptidase: Essential or Not Essential, That’s the Question

Molecular Biology

English

Review on the Laboratory Diagnosis of Yersinia Pestis

Journal of North Khorasan University of Medical Sciences

English

Yersinia Pestis: Mechanisms of Entry Into and Resistance to the Host Cell

Frontiers in Cellular and Infection Microbiology

Infectious Diseases

English

An Additional Step in the Transmission of Yersinia Pestis?

English

Molecular Characterization of IS1541Insertions in the Genome of Yersinia Pestis

Journal of Bacteriology

Molecular Biology

English